Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

InnovAge Holding (INNV) Shares Repurchased (2020 - 2025)

InnovAge Holding posted quarterly Shares Repurchased of -$297000.0 for Q2 2025, down 65.92% year-on-year from -$871524.6 in Q2 2024, and up 73.29% on a QoQ basis from -$1.1 million in Q1 2025.

InnovAge Holding (INNV) has 3 years of Shares Repurchased data on file, last reported at -$297000.0 in Q2 2025.

  • For the quarter ending Q2 2025, Shares Repurchased fell 65.92% year-over-year to -$297000.0; the trailing twelve-month figure through Mar 2026 stood at -$297000.0 (up 95.88% YoY), and the FY2025 full-year result was -$7.3 million, down 3989.94% from the prior year.
  • Shares Repurchased for Q2 2025 stood at -$297000.0, up from -$1.1 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at -$179000.0 in Q2 2024 and bottomed at -$4.8 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 1.57 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 318.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 196.37 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 71.60 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 163.85 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 190.04 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 InnovAge Holding 1.03 Bn 938.20 Mn 243.20 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -297,000.00
Jun 30, 2025 -297,000.00
Mar 31, 2025 -1.11 Mn
Mar 31, 2025 -1.11 Mn
Dec 31, 2024 -1.09 Mn
Dec 31, 2024 -1.09 Mn
Sep 30, 2024 -4.82 Mn
Sep 30, 2024 -4.82 Mn
Jun 30, 2024 -179,000.00
Jun 30, 2024 -179,000.00
Sep 30, 2020 77.60 Mn
Sep 30, 2020 77.60 Mn